Cingulate Inc. Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update
August 11, 2022 06:45 ET
|
Cingulate Inc.
$5 Million of Non-Dilutive FinancingVeteran Biotech Executive Appointed to Board KANSAS CITY, Kan., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage...
VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary
September 08, 2021 07:15 ET
|
VectivBio AG
BASEL, Switzerland, Sept. 08, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for...
Trevena Appoints Scott Applebaum as Chief Legal and Compliance Officer and SVP of Regulatory Affairs
February 13, 2020 07:00 ET
|
Trevena Inc.
CHESTERBROOK, Pa., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...
Seelos Therapeutics Announces the Addition of Scott Applebaum as Lead Strategic Regulatory Consultant
October 15, 2019 09:00 ET
|
Seelos Therapeutics, Inc.
NEW YORK, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, today announced the addition of Scott Applebaum to its team as lead...
Global Gene Therapy Market Analysis & Forecast to 2022: $350+ Million Market Strengthened by Recent Approvals of Kymriah, Yescarta and Luxturna in the US
March 07, 2018 06:57 ET
|
Research and Markets
Dublin, March 07, 2018 (GLOBE NEWSWIRE) -- The "Global Gene Therapy Market Analysis & Forecast to 2022" report has been added to ResearchAndMarkets.com's offering. The global...
Selecta Biosciences Announces Important Additions to Senior Leadership Team
October 26, 2017 08:00 ET
|
Selecta Biosciences, Inc.
Dr. John Leaman Named Chief Financial Officer and Head of Corporate StrategyStephen Smolinski Appointed Chief Commercial Officer WATERTOWN, Mass., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Selecta...
Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Strategic Business Report 2015-2022
July 04, 2017 07:00 ET
|
Research and Markets
Dublin, July 04, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics - Global Strategic...
Global Clinical Trial Supply and Logistics Market for Pharma 2017-2027
May 10, 2017 09:00 ET
|
Visiongain Ltd
LONDON, May 10, 2017 (GLOBE NEWSWIRE) -- Visiongain launches report on Manufacturing, Logistics and Distribution, Supply Chain Management, Packaging, Cold Chain Logistics. Report Published in...
Medgenics to Present at the 28th Annual Piper Jaffray Healthcare Conference
November 22, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Nov 22, 2016) - Medgenics, Inc. (NASDAQ: MDGN) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the 28th Annual Piper...
Medgenics to Present at the Jefferies London Healthcare Conference
November 09, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Nov 9, 2016) - Medgenics, Inc. (NASDAQ: MDGN) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the Jefferies London...